- $18.08bn
- $15.72bn
- $14.87bn
- 89
- 96
- 50
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,294 | 5,147 | 6,521 | 11,763 | 14,869 |
Cost of Revenue | |||||
Gross Profit | 2,187 | 1,059 | 1,922 | 4,693 | 6,200 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,462 | 5,813 | 5,814 | 8,829 | 10,552 |
Operating Profit | 832 | -666 | 708 | 2,933 | 4,316 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 934 | -619 | 1,243 | 3,166 | 4,633 |
Provision for Income Taxes | |||||
Net Income After Taxes | 731 | -642 | 1,053 | 2,549 | 3,958 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 743 | -634 | 1,100 | 2,553 | 3,918 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 743 | -634 | 1,100 | 2,553 | 3,918 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.629 | -0.193 | 0.989 | 2.31 | 3.3 |
Dividends per Share |